Verge Genomics

Verge Genomics

Biotechnology Research

South San Francisco, California 15,351 followers

Better drugs, faster. For patients who can’t wait.

About us

Verge Genomics is a clinical-stage biotechnology company transforming drug discovery and development using artificial intelligence (AI) and human data. Verge is focused on developing therapeutics for complex diseases with high unmet need, using human genomics from patient disease tissues and machine learning. Verge has created a proprietary all-in-human CONVERGE® platform, featuring one of the field’s largest and most comprehensive databases of multi-omic patient data. The company is led by experienced computational biologists and drug developers who are successfully advancing clinical and preclinical therapeutic programs in various diseases, including ALS and Parkinson’s disease. Verge actively seeks a diverse applicant pool in order to build the strongest possible workforce. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
South San Francisco, California
Type
Privately Held
Founded
2015
Specialties
Bioinformatics, Genomics, Drug Discovery, Neuroscience, ALS, and FTD

Locations

  • Primary

    131 Oyster Point Blvd

    South San Francisco, California 94080, US

    Get directions

Employees at Verge Genomics

Updates

Similar pages

Browse jobs

Funding

Verge Genomics 5 total rounds

Last Round

Series unknown
See more info on crunchbase